• -
  • English
  • Japanese
  • Korean
表紙
市場調查報告書
商品編碼
1025421

腎臟替代療法市場:2021∼2027年

Renal Replacement Therapy Market 2021-2027
出版日期: | 出版商: Orion Market Research Pvt Ltd | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球腎臟替代療法的市場規模在預測期間內預計將以約7.3％大幅度的年複合成長率擴大。促進這個市場成長的主要原因有全球性急性腎障礙(AKI)的增加和慢性疾病的增加。ICU 患者數量的增加預計將推動市場增長、膿毒症患病率的增加以及技術擴張的增加也成為市場驅動力。此外，腎臟替代治療程序的高成本預計將阻礙預測期內的市場增長。政府對連續腎臟替代治療的嚴格規定以及缺乏熟練的專業人員進行連續腎臟替代治療正在製約腎臟替代治療市場的增長。

由於 COVID-19 大流行，全球腎臟替代療法產生了積極影響。COVID-19 對既往患有慢性病的患者來說可能更嚴重。與同期發生 AKI 的非 COVID 患者相比，感染 COVID-19 的患者更有可能診斷出急性腎損傷 (AKI)。根據國家腎臟基金會的說法，透析患者的免疫系統可能較弱，因此更難抵抗 Covid-19 感染。此外，患有腎臟疾病的患者需要繼續他們定期安排的透析治療。因此，明確指出該市場不會因 COVID-19 大流行而受到打擊或面臨任何損失。

本報告提供腎臟替代療法市場相關調查，提供市場概要，以及治療各類型，各終端用戶，各地區的趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

  • 調查範圍
  • 分析師的洞察和目前市場趨勢

第3章 競爭情形

  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
    • 最近的趨勢
  • 重要的策略分析
  • Covid-19對主要參與者的影響

第4章 市場決策要素

  • 成長要素
  • 阻礙因素
  • 市場機會

第5章 市場細分化

  • 全球腎臟替代療法市場，治療各類型
    • 透析
    • 血液過濾
    • 血液透析機過濾
    • 腎臟移植
  • 全球腎臟替代療法市場，各終端用戶
    • 醫院及診療所
    • 研究查機關

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他
  • 其他地區

第7章 企業簡介

  • AngioDynamics
  • Asahi Kasei Corp.
  • B. Braun Melsungen AG
  • Baxter.
  • C. R. Bard, Inc.
  • Cantel Medical.
  • CryoLife, Inc.
  • DaVita Inc.
  • Diaverum Corporate
  • Fresenius Medical Care AG & Co.
  • Hebei Ziweishan Pharmaceutical Co., Ltd.
  • Isopure Corp.
  • JMS Co., Ltd.
  • Kawasumi Laboratories, Inc.
  • Medical, Inc.
  • Medtronic PLC
  • Nikkiso Co. Ltd.
  • NxStage Medical, Inc
  • Renacon Pharma Ltd.
目錄
Product Code: OMR2023852

Full-title:Global Renal Replacement Therapy Market Size, Share & Trends Analysis Report By Therapy Type (Dialysis, Hemodialysis, Peritoneal Dialysis), By End-User (Hospitals and Clinics, Research Institutes) Forecast, 2021-2027.

The global renal replacement therapy market is anticipated to grow at a considerable CAGR of around 7.3% during the forecast period. The key factors that impel the growth of the market include the rising prevalence of acute kidney injury (AKI) and the increasing prevalence of the chronic disease across the globe. The increasing number of ICU Patients is expected to boost the market growth, increasing prevalence of Sepsis, and increasing technological expansion also acts as a market driver. Moreover, the high cost of renal replacement therapy procedures is expected to hinder the market growth in the forecasted period. Additionally, strict government rules for continuous renal replacement therapy and the absence of skilled professionals to perform constant renal replacement therapy are fettering the growth of the renal replacement therapy market.

Global renal replacement therapy has a positive impact due to the COVID-19 pandemic. COVID-19 can be more severe to patients with prior chronic diseases. COVID-19 infected patient has more chance to diagnose with Acute kidney injury (AKI) as compared to non-COVID patients who developed AKI during the same period. According to the National Kidney Foundation, the patients on dialysis can have weaker immune systems making it tougher to fight Covid-19 infection. Also, the patients having kidney disease require to continue their regularly scheduled dialysis treatments. Hence, is specify that this market is not hit or faced any losses due to COVID-19 Pandemic.

The global renal replacement market is segmented based on therapy type and end-user. Based on therapy type, the global renal replacement market is segmented into dialysis, hemodialysis, and peritoneal dialysis. Based on the therapy type, the global renal replacement market is segmented into hospitals and clinics, research institutes.

The global renal replacement therapy market is evaluated based on the geographical regions that are contributing considerably to growth towards the growth of the market. Based on the geography, North America holds a considerable market share due to the region has well-established healthcare facilities allowing the proper therapies of the patients, North America has an increasing incidence of AKI due to the rapidly increasing number of geriatric population. North America has a high increasing number of approvals for CRRT systems of (CRRT) continuous renal replacement therapy drives the growth of the renal replacement therapy market in the region. Additionally, the Asia-Pacific region is anticipated significant growth in the renal replacement therapy market during the forecasted period.  Due to the increasing number of kidney-related problems, and increasing prevalence of chronic diseases in Asia-Pacific. Moreover, government initiatives and R&D boost the growth of the renal replacement therapy market in Asia-Pacific.

Research Methodology

The market study of the global renal replacement therapy market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • Global Renal Replacement Therapy Market Research and Analysis by Approach
  • Global Renal Replacement Therapy Market Research and Analysis by Application
  • Global Renal Replacement Therapy Market Research and Analysis by End-user

The Report Covers

  • Comprehensive research methodology of the Global Renal Replacement Therapy market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Global Renal Replacement Therapy market.
  • Insights about market determinants that are stimulating the Global Renal Replacement Therapy market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Renal Replacement Therapy Industry
  • Recovery Scenario of Global Renal Replacement Therapy Industry
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of Covid-19on Key Players

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Renal Replacement Therapy Market by Therapy Type
    • 5.1.1. Dialysis
      • 5.1.1.1. Hemodialysis
      • 5.1.1.2. Peritoneal Dialysis
    • 5.1.2. Hemofiltration
    • 5.1.3. Hemodiafiltration
    • 5.1.4. Kidney Transplantation
  • 5.2. Global Renal Replacement Therapy Market by End-User
    • 5.2.1. Hospitals and Clinics
    • 5.2.2. Research Institutes

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. AngioDynamics
  • 7.2. Asahi Kasei Corp.
  • 7.3. B. Braun Melsungen AG
  • 7.4. Baxter.
  • 7.5. C. R. Bard, Inc.
  • 7.6. Cantel Medical.
  • 7.7. CryoLife, Inc.
  • 7.8. DaVita Inc.
  • 7.9. Diaverum Corporate
  • 7.10. Fresenius Medical Care AG & Co.
  • 7.11. Hebei Ziweishan Pharmaceutical Co., Ltd.
  • 7.12. Isopure Corp.
  • 7.13. JMS Co., Ltd.
  • 7.14. Kawasumi Laboratories, Inc.
  • 7.15. Medical, Inc.
  • 7.16. Medtronic PLC
  • 7.17. Nikkiso Co. Ltd.
  • 7.18. NxStage Medical, Inc
  • 7.19. Renacon Pharma Ltd.

LIST OF TABLES

  • 1. GLOBAL RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS,2020-2027 ($ MILLION)
  • 2. GLOBAL RENAL REPLACEMENT THERAPY MARKET BYTHERAPY TYPE,2020-2027 ($ MILLION)
  • 3. GLOBAL DIALYSISMARKET BY REGION,2020-2027 ($ MILLION)
  • 4. GLOBAL HEMODIALYSISMARKET BY REGION,2020-2027 ($ MILLION)
  • 5. GLOBAL PERITONEAL DIALYSIS MARKET BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL RENAL REPLACEMENT THERAPY MARKET BYEND-USER,2020-2027 ($ MILLION)
  • 7. GLOBALRENAL REPLACEMENT THERAPY IN HOSPITALS AND CLINICSMARKET BY REGION,2020-2027 ($ MILLION)
  • 8. GLOBALRENAL REPLACEMENT THERAPY IN RESEARCH INSTITUTESMARKET BY REGION,2020-2027 ($ MILLION)
  • 9. GLOBALRENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 10. NORTH AMERICANRENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BYCOUNTRY, 2020-2027 ($ MILLION)
  • 11. NORTH AMERICANRENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY THERAPY TYPE, 2020-2027 ($ MILLION)
  • 12. NORTH AMERICANRENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY, END-USER 2020-2027 ($ MILLION)
  • 13. EUROPEAN RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BYCOUNTRY, 2020-2027 ($ MILLION)
  • 14. EUROPEAN RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY THERAPY TYPE, 2020-2027 ($ MILLION)
  • 15. EUROPEAN RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY, END-USER 2020-2027 ($ MILLION)
  • 16. ASIA-PACIFIC RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BYCOUNTRY, 2020-2027 ($ MILLION)
  • 17. ASIA-PACIFIC RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY THERAPY TYPE, 2020-2027 ($ MILLION)
  • 18. ASIA-PACIFIC RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY, END-USER 2020-2027 ($ MILLION)
  • 19. REST OF THE WORLD RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY THERAPY TYPE, 2020-2027 ($ MILLION)
  • 20. REST OF THE WORLD RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY, END-USER 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL RENAL REPLACEMENT THERAPY, 2020-2027 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL RENAL REPLACEMENT THERAPY MARKET BY SEGMENT, 2020-2027 ($ MILLION)
  • 3. RECOVERY OF GLOBAL RENAL REPLACEMENT THERAPY MARKET, 2021-2027 (%)
  • 4. GLOBAL RENAL REPLACEMENT THERAPY MARKET SHARE BY THERAPY TYPE, 2020 VS 2027 (%)
  • 5. GLOBAL RENAL REPLACEMENT THERAPY MARKET SHARE BY END-USER, 2020 VS 2027 (%)
  • 6. GLOBAL DIALYSIS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 7. GLOBAL HEMODIALYSIS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 8. GLOBAL PERITONEAL DIALYSIS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 9. GLOBALRENAL REPLACEMENT THERAPYIN HOSPITALS AND CLINICS MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 10. GLOBALRENAL REPLACEMENT THERAPY IN RESEARCH INSTITUTES MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 11. US RENAL REPLACEMENT THERAPY MARKET SIZE, 2020-2027 ($ MILLION)
  • 12. CANADA RENAL REPLACEMENT THERAPY MARKET SIZE, 2020-2027 ($ MILLION)
  • 13. UK RENAL REPLACEMENT THERAPY MARKET SIZE, 2020-2027 ($ MILLION)
  • 14. GERMANY RENAL REPLACEMENT THERAPY MARKET SIZE, 2020-2027 ($ MILLION)
  • 15. SPAIN RENAL REPLACEMENT THERAPY MARKET SIZE, 2020-2027 ($ MILLION)
  • 16. FRANCE RENAL REPLACEMENT THERAPY MARKET SIZE, 2020-2027 ($ MILLION)
  • 17. ITALY RENAL REPLACEMENT THERAPY MARKET SIZE, 2020-2027 ($ MILLION)
  • 18. REST OF EUROPE RENAL REPLACEMENT THERAPY MARKET SIZE, 2020-2027 ($ MILLION)
  • 19. INDIA RENAL REPLACEMENT THERAPY MARKET SIZE, 2020-2027 ($ MILLION)
  • 20. CHINA RENAL REPLACEMENT THERAPY MARKET SIZE, 2020-2027 ($ MILLION)
  • 21. JAPAN RENAL REPLACEMENT THERAPY MARKET SIZE, 2020-2027 ($ MILLION)
  • 22. SOUTH KOREA RENAL REPLACEMENT THERAPY MARKET SIZE, 2020-2027 ($ MILLION)
  • 23. REST OF ASIA-PACIFIC RENAL REPLACEMENT THERAPY MARKET SIZE, 2020-2027 ($ MILLION)
  • 24. REST OF WORLD RENAL REPLACEMENT THERAPY MARKET SIZE, 2020-2027 ($ MILLION)